These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 33450401)

  • 1. Dr. Sprengers et al. Reply.
    Sprengers JJ; van Andel DM; Bruining H
    J Am Acad Child Adolesc Psychiatry; 2021 Aug; 60(8):938-939. PubMed ID: 33450401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treating Autism With Bumetanide: Are Large Multicentric and Monocentric Trials on Selected Populations Complementary?
    Lemonnier E; Rabiei H; Makowski D; Hadjikhani N; Ben-Ari Y
    J Am Acad Child Adolesc Psychiatry; 2021 Aug; 60(8):937-938. PubMed ID: 33385505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Editorial: Targeting the Core Symptoms of Autism Spectrum Disorder With Mechanism-Based Medications.
    Vitiello B
    J Am Acad Child Adolesc Psychiatry; 2021 Jul; 60(7):816-817. PubMed ID: 33212159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The GABA Polarity Shift and Bumetanide Treatment: Making Sense Requires Unbiased and Undogmatic Analysis.
    Ben-Ari Y; Cherubini E
    Cells; 2022 Jan; 11(3):. PubMed ID: 35159205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bumetanide, a Diuretic That Can Help Children with Autism Spectrum Disorder.
    Shaker E; El Agami O; Salamah A
    CNS Neurol Disord Drug Targets; 2024; 23(4):536-542. PubMed ID: 37021422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Symptom improvement in children with autism spectrum disorder following bumetanide administration is associated with decreased GABA/glutamate ratios.
    Zhang L; Huang CC; Dai Y; Luo Q; Ji Y; Wang K; Deng S; Yu J; Xu M; Du X; Tang Y; Shen C; Feng J; Sahakian BJ; Lin CP; Li F
    Transl Psychiatry; 2020 Jan; 10(1):9. PubMed ID: 32066666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of bumetanide on neurodevelopmental impairments in patients with tuberous sclerosis complex: an open-label pilot study.
    van Andel DM; Sprengers JJ; Oranje B; Scheepers FE; Jansen FE; Bruining H
    Mol Autism; 2020 May; 11(1):30. PubMed ID: 32381101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved symptoms following bumetanide treatment in children aged 3-6 years with autism spectrum disorder: a randomized, double-blind, placebo-controlled trial.
    Dai Y; Zhang L; Yu J; Zhou X; He H; Ji Y; Wang K; Du X; Liu X; Tang Y; Deng S; Langley C; Li WG; Zhang J; Feng J; Sahakian BJ; Luo Q; Li F
    Sci Bull (Beijing); 2021 Aug; 66(15):1591-1598. PubMed ID: 36654288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of Bumetanide on Neurocognitive Functioning in Children with Autism Spectrum Disorder: Secondary Analysis of a Randomized Placebo-Controlled Trial.
    van Andel DM; Sprengers JJ; Königs M; de Jonge MV; Bruining H
    J Autism Dev Disord; 2024 Mar; 54(3):894-904. PubMed ID: 36626004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The immuno-behavioural covariation associated with the treatment response to bumetanide in young children with autism spectrum disorder.
    Li Q; Zhang L; Shan H; Yu J; Dai Y; He H; Li WG; Langley C; Sahakian BJ; Yao Y; Luo Q; Li F
    Transl Psychiatry; 2022 Jun; 12(1):228. PubMed ID: 35660740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bumetanide for Core Symptoms of Autism Spectrum Disorder (BAMBI): A Single Center, Double-Blinded, Participant-Randomized, Placebo-Controlled, Phase-2 Superiority Trial.
    Sprengers JJ; van Andel DM; Zuithoff NPA; Keijzer-Veen MG; Schulp AJA; Scheepers FE; Lilien MR; Oranje B; Bruining H
    J Am Acad Child Adolesc Psychiatry; 2021 Jul; 60(7):865-876. PubMed ID: 32730977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between absolute and relative ratios of glutamate, glutamine and GABA and severity of autism spectrum disorder.
    Al-Otaish H; Al-Ayadhi L; Bjørklund G; Chirumbolo S; Urbina MA; El-Ansary A
    Metab Brain Dis; 2018 Jun; 33(3):843-854. PubMed ID: 29397522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dysregulation of Neurite Outgrowth and Cell Migration in Autism and Other Neurodevelopmental Disorders.
    Prem S; Millonig JH; DiCicco-Bloom E
    Adv Neurobiol; 2020; 25():109-153. PubMed ID: 32578146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tactile hypersensitivity and GABA concentration in the sensorimotor cortex of adults with autism.
    Sapey-Triomphe LA; Lamberton F; Sonié S; Mattout J; Schmitz C
    Autism Res; 2019 Apr; 12(4):562-575. PubMed ID: 30632707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thalamic and prefrontal GABA concentrations but not GABA
    Fung LK; Flores RE; Gu M; Sun KL; James D; Schuck RK; Jo B; Park JH; Lee BC; Jung JH; Kim SE; Saggar M; Sacchet MD; Warnock G; Khalighi MM; Spielman D; Chin FT; Hardan AY
    Mol Psychiatry; 2021 May; 26(5):1634-1646. PubMed ID: 32376999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomised controlled trial of bumetanide in the treatment of autism in children.
    Lemonnier E; Degrez C; Phelep M; Tyzio R; Josse F; Grandgeorge M; Hadjikhani N; Ben-Ari Y
    Transl Psychiatry; 2012 Dec; 2(12):e202. PubMed ID: 23233021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Association Between Somatic Health, Autism Spectrum Disorder, and Autistic Traits.
    Pan PY; Tammimies K; Bölte S
    Behav Genet; 2020 Jul; 50(4):233-246. PubMed ID: 31811521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Wholistic View of How Bumetanide Attenuates Autism Spectrum Disorders.
    Delpire E; Ben-Ari Y
    Cells; 2022 Aug; 11(15):. PubMed ID: 35954263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glutamate and GABA in autism spectrum disorder-a translational magnetic resonance spectroscopy study in man and rodent models.
    Horder J; Petrinovic MM; Mendez MA; Bruns A; Takumi T; Spooren W; Barker GJ; Künnecke B; Murphy DG
    Transl Psychiatry; 2018 May; 8(1):106. PubMed ID: 29802263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mood Stabilizers in Children and Adolescents With Autism Spectrum Disorders.
    Canitano R
    Clin Neuropharmacol; 2015; 38(5):177-82. PubMed ID: 26366961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.